[Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model].
D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D004195:Disease Models, Animal; D005688:Galactosamine; D007538:Isoniazid / Q000009:adverse effects*; D008099:Liver / Q000187:drug effects; D008297:Male; D051381:Rats; D012293:Rifampin / Q000009:adverse effects*
D005688:Galactosamine; D007538:Isoniazid; D012293:Rifampin
Tierexperimentelle Untersuchungen zur Frage der Leberschädigung durch Tuberkulostatika (Rifampicin und Isoniacid) anhand des Galaktosaminmodells.